This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Melior Pharmaceuticals I, Inc.. Active years: 2013-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2024
Title: Alexander R. Ochman: Innovator in Diabetes Treatment
Introduction
Alexander R. Ochman is a notable inventor based in Exton, PA (US), recognized for his contributions to medical science, particularly in the field of diabetes treatment. With a total of 2 patents, he has made significant strides in developing innovative solutions for managing glucose metabolism and preventing pancreatic cell degeneration.
Latest Patents
Ochman's latest patents include groundbreaking inventions aimed at addressing critical health issues. The first patent focuses on the prevention of pancreatic cell degeneration, detailing compounds and pharmaceutically acceptable salts that are effective in preventing pancreatic beta cell degeneration. This invention is particularly relevant for treating disorders associated with pancreatic beta cell degeneration, such as type I diabetes. The second patent involves compounds and methods for treating disorders related to glucose metabolism. This invention is designed to modulate lyn kinase activity, which is essential for treating obesity, type II diabetes, and metabolic syndrome, while also reducing blood glucose levels and weight gain.
Career Highlights
Ochman is currently associated with Melior Pharmaceuticals Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His work is pivotal in developing therapies that can significantly improve the quality of life for individuals suffering from diabetes and related conditions.
Collaborations
Throughout his career, Ochman has collaborated with esteemed colleagues, including Andrew G. Reaume and Michael S. Saporito. These partnerships have fostered a collaborative environment that enhances the development of effective medical solutions.
Conclusion
Alexander R. Ochman stands out as a dedicated inventor whose work in diabetes treatment is making a meaningful impact. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile